penetration into u.s drug market begins

shares oversubscribed at 1.5c which makes today's 1.3c better than a poke in the eye.

sales progress looks like a good next quarter

interest in the stock ( americans love pharma' stocks) could baloon when marketing of the drugs and drug delivery gets underway.

market depth has swung since this mornings open from 45m on the total buy side and 58m on the total sell side to 62m/ 54m then to current 66m / 56m

etrade still hasn't got announcement able to be read

comsec has notice and accessible which means etrade clients haven't seen the news yet.

32m volume at time of post, trading 1.3c up one tenth or 8.33%.